Alternative widely available, inexpensive agents for pleurodesis

Dikensoy Ö., Light R.

CURRENT OPINION IN PULMONARY MEDICINE, vol.11, no.4, pp.340-344, 2005 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 4
  • Publication Date: 2005
  • Doi Number: 10.1097/01.mcp.0000166587.24127.91
  • Journal Name: CURRENT OPINION IN PULMONARY MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.340-344
  • Keywords: iodopoviclone, oral tetracycline, pleurodesis, quinacrine, silver nitrate, MALIGNANT PLEURAL EFFUSIONS, SILVER-NITRATE PLEURODESIS, 1-YEAR FOLLOW-UP, SPONTANEOUS PNEUMOTHORAX, NEOPLASTIC EFFUSIONS, CYSTIC-FIBROSIS, QUINACRINE, TALC, TETRACYCLINE, MANAGEMENT
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Purpose of review Pleurodesis is the one of the best options for the management of symptomatic patients with malignant pleural effusion, recurrent benign pleural effusion, and recurrent pneumothorax. Although talc, parenteral tetracycline derivatives, and bleomycin are the most commonly used agents for pleurodesis, parenteral tetracycline derivatives are not available worldwide, bleomycin is expensive, and concerns about the side effects of talc are growing. The purpose of this review is to provide information about other widely available agents for pleurodesis.